Cite
Fleischmann M, Schnetzke U, Frietsch JJ, et al. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia. J Cancer Res Clin Oncol. 2021;doi: 10.1007/s00432-021-03733-0.
Fleischmann, M., Schnetzke, U., Frietsch, J. J., Sayer, H. G., Schrenk, K., Hammersen, J., Glaser, A., Hilgendorf, I., Hochhaus, A., & Scholl, S. (2021). Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia. Journal of cancer research and clinical oncology, . https://doi.org/10.1007/s00432-021-03733-0
Fleischmann, Maximilian, et al. "Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia." Journal of cancer research and clinical oncology vol. (2021). doi: https://doi.org/10.1007/s00432-021-03733-0
Fleischmann M, Schnetzke U, Frietsch JJ, Sayer HG, Schrenk K, Hammersen J, Glaser A, Hilgendorf I, Hochhaus A, Scholl S. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia. J Cancer Res Clin Oncol. 2021 Jul 23; doi: 10.1007/s00432-021-03733-0. Epub 2021 Jul 23. PMID: 34297206.
Copy
Download .nbib
